Gilead Sciences and CymaBay Therapeutics announced today a definitive agreement under which Gilead will acquire CymaBay for $32.50 per share in cash or a total equity value of $4.3 billion. The addition of CymaBay’s investigational lead product candidate, seladelpar for…
Novartis today announced that it has entered into an agreement to make a voluntary public takeover offer to acquire MorphoSys, a Germany-based, global biopharmaceutical company developing innovative medicines in oncology. The acquisition, which is subject to customary closing conditions, including…
Supported by the Singapore Economic Development Board (EDB), the Digital Hub aims to propel advancements within the healthcare and semiconductor industries. Singapore is recognized globally for driving innovation and digital excellence, particularly in key areas such as digital health, semiconductor…
AbbVie strengthened its manufacturing capabilities by breaking ground Thursday on a new US$223 million expansion of its Singapore manufacturing facility. This new investment will add more than 100 jobs and new biologics manufacturing capacity to AbbVie’s global network. Located in…
Takeda is one of just 17 companies that received global recognition, and it was additionally certified as a Top Employer across 24 countries. The Top Employers Institute program certifies organizations based on the participation and results of their HR Best…
Helen Basford PCC, Global Capability Lead, Coaching & Feedforward, AstraZeneca, discusses how a forward-looking coaching approach can help our employees learn, adapt and grow so we can continue to overcome novel challenges and push the boundaries of science: Coaching capability…
Chiesi Group, has been awarded the 59th Oscar di Bilancio for the Benefit Corporation category, sponsored by Federazione Relazioni Pubbliche Italiana, Borsa Italiana and Università Bocconi. The award ceremony entitled “Shared Value – The Future of Reporting is Written Today”…
Roche has again been recognised as one of the most sustainable companies in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI). Roche ranked third, Chugai Pharmaceuticals, a member of the Roche Group, ranked second. “We are extremely proud…
Pfizer today announced the successful completion of its acquisition of Seagen, a global biotechnology company that discovers, develops and commercializes transformative cancer medicines. Pfizer completed its acquisition of all outstanding common stock of Seagen for $229 in cash per share,…
For the second year running, Servier has awarded the Servier Discovery Award to a Californian life sciences start-up. For the 2023 edition, Palm Therapeutics was rewarded for its innovative platform and approach in precision oncology drug development. Servier takes an…